Vanguard Group
CLSD icon

Vanguard Group’s Clearside Biomedical CLSD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.69M Buy
3,363,061
+556,454
+20% +$445K ﹤0.01% 3434
2025
Q1
$2.58M Hold
2,806,607
﹤0.01% 3402
2024
Q4
$2.67M Sell
2,806,607
-33,371
-1% -$31.7K ﹤0.01% 3480
2024
Q3
$3.61M Hold
2,839,978
﹤0.01% 3386
2024
Q2
$3.69M Buy
2,839,978
+349,182
+14% +$454K ﹤0.01% 3379
2024
Q1
$3.81M Buy
2,490,796
+314,480
+14% +$481K ﹤0.01% 3398
2023
Q4
$2.55M Buy
2,176,316
+9,431
+0.4% +$11K ﹤0.01% 3515
2023
Q3
$1.88M Hold
2,166,885
﹤0.01% 3607
2023
Q2
$2.43M Hold
2,166,885
﹤0.01% 3591
2023
Q1
$2.25M Hold
2,166,885
﹤0.01% 3629
2022
Q4
$2.43M Buy
2,166,885
+1,208
+0.1% +$1.35K ﹤0.01% 3596
2022
Q3
$2.45M Hold
2,165,677
﹤0.01% 3670
2022
Q2
$3.18M Hold
2,165,677
﹤0.01% 3599
2022
Q1
$4.96M Sell
2,165,677
-9,475
-0.4% -$21.7K ﹤0.01% 3536
2021
Q4
$5.98M Sell
2,175,152
-3,020
-0.1% -$8.31K ﹤0.01% 3511
2021
Q3
$13.1M Buy
2,178,172
+72,082
+3% +$432K ﹤0.01% 3093
2021
Q2
$10.3M Buy
2,106,090
+378,559
+22% +$1.84M ﹤0.01% 3186
2021
Q1
$4.27M Buy
1,727,531
+36,790
+2% +$90.9K ﹤0.01% 3610
2020
Q4
$4.63M Buy
1,690,741
+48,077
+3% +$132K ﹤0.01% 3394
2020
Q3
$2.53M Buy
1,642,664
+50,568
+3% +$77.9K ﹤0.01% 3419
2020
Q2
$2.99M Sell
1,592,096
-43,349
-3% -$81.5K ﹤0.01% 3315
2020
Q1
$2.78M Buy
1,635,445
+575,055
+54% +$978K ﹤0.01% 3206
2019
Q4
$3.08M Buy
1,060,390
+25,725
+2% +$74.6K ﹤0.01% 3329
2019
Q3
$652K Buy
1,034,665
+110,180
+12% +$69.4K ﹤0.01% 3756
2019
Q2
$899K Buy
924,485
+370,690
+67% +$360K ﹤0.01% 3700
2019
Q1
$764K Sell
553,795
-5,810
-1% -$8.02K ﹤0.01% 3693
2018
Q4
$598K Sell
559,605
-696,057
-55% -$744K ﹤0.01% 3699
2018
Q3
$7.72M Buy
1,255,662
+27,178
+2% +$167K ﹤0.01% 3052
2018
Q2
$13.1M Buy
1,228,484
+79,769
+7% +$853K ﹤0.01% 2767
2018
Q1
$12.3M Buy
1,148,715
+376,500
+49% +$4.04M ﹤0.01% 2728
2017
Q4
$5.41M Buy
772,215
+51,958
+7% +$364K ﹤0.01% 3101
2017
Q3
$6.3M Buy
720,257
+18,707
+3% +$163K ﹤0.01% 3020
2017
Q2
$6.39M Buy
701,550
+70,488
+11% +$642K ﹤0.01% 2994
2017
Q1
$5.01M Buy
631,062
+45,657
+8% +$363K ﹤0.01% 3051
2016
Q4
$5.23M Buy
585,405
+253,679
+76% +$2.27M ﹤0.01% 3045
2016
Q3
$5.76M Buy
+331,726
New +$5.76M ﹤0.01% 2937